Fenofibrate Intervention and Event Lowering in Diabetes.
Latest Information Update: 29 Jul 2023
At a glance
- Drugs Fenofibrate (Primary)
- Indications Cardiovascular disorders; Coronary disorders; Diabetic complications; Diabetic retinopathy; Myocardial infarction; Stroke
- Focus Therapeutic Use
- Acronyms FIELD
- Sponsors Fournier Pharma
Most Recent Events
- 01 Jul 2023 Results of a post-hoc analysis assessing association between diabetic microvascular complications with bone fragility using data from this trial published in the Diabetes/Metabolism Research and Reviews
- 01 Apr 2022 Results (n=208) published in the Internal Medicine Journal
- 30 Mar 2020 Results exploring associations between lipoprotein subfractions and apoproteins and risk for ischemic stroke in the FIELD trial presented at the 2020 Annual Scientific Session of the American College of Cardiology and World Congress of Cardiology